Expansion of hospice housing and end-to-end support for the patient experience through the capital and business alliance with SUGI HOLDINGS Co.,LTD.
First written in FY2023-Q2. 8 of 9 entries say "Advanced", first in FY2023. Latest entry: 2026-08-14.
3 other companies' latest entry also says "Advanced".
- FY2025AdvancedAnnual report
「また、施設で働く看護師の育成にも注力しており、緩和ケアを提供する看護師に必須とされる能力修得のための終末期ケアの看護師包括教育プログラム「ELNEC-J」や資本業務提携先であるスギホールディングス株式会社が運営するスギ薬局による医療用麻薬等の薬剤研修を実施し、看護師のスキルアップを図っております。」
スギホールディングスとの資本業務提携を、スギ薬局による医療用麻薬等の薬剤研修という具体的な人材育成施策にも展開。 - 2026-03-04AdvancedGeneral Meetings of Shareholders
「With the quality of hospice care, which we have improved through the education and training we have consistently emphasized since our founding, as the foundation, we intend to move the hospice business forward decisively by promoting various projects with SUGI HOLDINGS Co.,LTD. and other initiatives.」
The company stated its policy of promoting various projects with SUGI HOLDINGS Co.,LTD. in conjunction with the quality of care developed through education and training. - FY2024AdvancedAnnual report
「2024年３月 当社取締役就任（現任）」
資本業務提携先であるスギ薬局の店舗開発本部副本部長が2024年3月に当社取締役へ就任したことを記載している。 - FY2023AdvancedAnnual report
「スギホールディングスは、2023年７月３日付で当社普通株式1,600,000株（発行済株式総数の19.91%）を取得いたしました。」
資本業務提携に基づくスギホールディングスの株式取得が実行され、同社が主要株主となった。提携内容にはホスピス住宅の共同開発・物品供給・サービス融合、居宅からホスピス施設への連携体制構築が含まれ、2024年3月にはスギ薬局の店舗開発本部副本部長が当社取締役に就任した。 - FY2023-Q2First statedAnnual report
「This capital and business alliance will further strengthen the cooperative relationship between the two groups. We believe it will promote the development of the hospice residence business and enhance user satisfaction and engagement by establishing a system that provides seamless support throughout the patient experience, from inpatient and outpatient care through home healthcare and long-term care and subsequently home healthcare and long-term care at hospice residences.」
On 16 June 2023, entered into a capital and business alliance agreement with SUGI HOLDINGS Co.,LTD. SUGI HOLDINGS Co.,LTD. acquired 1,600,000 common shares on 3 July 2023, representing 19.91% of issued shares, and obtained the right to nominate 1 director candidate, among other rights. Planned business initiatives include raising awareness of hospice residences, providing and jointly developing new properties, ensuring stable supplies of goods for residents, integrating services to provide palliative care, and establishing referral arrangements from homes to hospice facilities.